113 related articles for article (PubMed ID: 6958253)
21. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
23. Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: report of a case with immunocytochemical features.
Kobayashi TK; Teraoka S; Tsujioka T; Yoshida Y
Diagn Cytopathol; 1988; 4(3):234-8. PubMed ID: 2474417
[TBL] [Abstract][Full Text] [Related]
24. [Determination of carcinoembryonic antigen in effusion fluids].
Salas H; Louvet H; Zeitoun P; Deltour G
Nouv Presse Med; 1979 Feb; 8(7):526-7. PubMed ID: 461169
[No Abstract] [Full Text] [Related]
25. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
26. Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.
Wilhelm O; Hafter R; Coppenrath E; Pflanz MA; Schmitt M; Babic R; Linke R; Gössner W; Graeff H
Cancer Res; 1988 Jun; 48(12):3507-14. PubMed ID: 3130986
[TBL] [Abstract][Full Text] [Related]
27. Chylous ascites.
Manten H; Barkin JS; Rogers AI
Postgrad Med; 1982 Jun; 71(6):79-84. PubMed ID: 6210902
[No Abstract] [Full Text] [Related]
28. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
Harlozinska A; Bar JK; Richter R; Cislo M
Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma.
Hill R; Khoo SK; Daunter B; Silburn PA; Mackay EV
Int J Cancer; 1982 Nov; 30(5):587-92. PubMed ID: 7152721
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
[TBL] [Abstract][Full Text] [Related]
31. [Gas chromatographic analysis of fatty acids of ascitic fluid in ovarian carcinoma].
Lantieri PB; Ciangherotti S; Bentivoglio G; Diani F
Boll Soc Ital Biol Sper; 1981 Aug; 57(15):1627-9. PubMed ID: 7306405
[No Abstract] [Full Text] [Related]
32. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
33. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
Halila H; Huhtala ML; Haglund C; Nordling S; Stenman UH
Br J Cancer; 1987 Aug; 56(2):153-6. PubMed ID: 3117086
[TBL] [Abstract][Full Text] [Related]
34. Ovarian tumor antigens: preliminary histological investigation.
Daunter B; Jaa-Kwee D; Miklosi S; Wright G
Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
[TBL] [Abstract][Full Text] [Related]
35. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
36. Isolation of tumor-specific antibodies from effusions of ovarian carcinomas.
Dorsett BH; Ioachim HL; Stolbach L; Walker J; Barber HR
Int J Cancer; 1975 Nov; 16(5):779-86. PubMed ID: 1184243
[TBL] [Abstract][Full Text] [Related]
37. [Determination of carcinoembryonic antigen in puncture fluid of cystic ovarian tumors and ovarian cysts].
Büttner HH; Kunze M; Voss P
Gynakol Rundsch; 1988; 28 Suppl 2():179-80. PubMed ID: 3234915
[No Abstract] [Full Text] [Related]
38. [Ganglioside content and profile in the ovarian tumor tissues and in the biological body fluids of patients].
Novikov AM; Makhova EE; Travnikov ME; Bassalyk LS
Eksp Onkol; 1989; 11(3):52-5. PubMed ID: 2752944
[TBL] [Abstract][Full Text] [Related]
39. Immunological comparison of ovarian and colonic CEA.
Burtin P; Lamerz R; Gendron MC; Maunoury MT; Schnabel G
Immunol Lett; 1982 Feb; 4(2):87-91. PubMed ID: 6174431
[TBL] [Abstract][Full Text] [Related]
40. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
